Categories
Part D Prescription Drug

Is the new Novo Nordisk “improved” insulin worth a 60-70% price hike? The market says ‘no.’

My clients regularly ask why brand name medications are so expensive. This great article by WSJ reporter Denise Roland helps explain the game. “In traditional marketing, a product line extension is the use of an established brand name for a new item with new flavors, forms, colors, added ingredients, package sizes.” Novo Nordisk repackaged its […]

Categories
Part D Prescription Drug

Medicare Issues Projected Drug Premiums for 2018

CMS reports the average 2018 monthly premium for a basic Part D prescription drug plan will be reduced by $1.20 to $33.50. In addition to the monthly premium other Part D variables Medicare beneficiaries should compare are: Plan Formulary – not all plans are alike. Check and confirm your medication is included in the list […]